Research Groups and R&D Platforms: Diabetes
Research Group:
Molecular imaging of atherosclerosis and heart failure
Antti Saraste
antti.saraste[at]utu.fi
Heart Center and PET Center,
University of Turku
Basic research, Biomarker, Cardiovascular diseases, Clinical Medicine, Diabetes, Disease models, Imaging, In Vivo Diagnostics, Inflammation, PET, Target discovery, Ultrasound imaging
Research Group:
Alpha2-Adrenoceptors as targets for drug development
Mika Scheinin
mschein[at]utu.fi
University of Turku, Turku University Hospital and CRST Oy
Clinical Research Services Turku
Ageing-related diseases, Allergy, Antibodies, Assay development, Asthma, Autoimmune diseases, Basic research, Biomarker, Biomedicine, Biopharmaceuticals, Cancer, Cardiovascular diseases, Clinical Medicine, Diabetes, Diagnostics, Disease models, Drug delivery, Drug target, Endocrinology, Imaging, In Vitro Diagnostics, In Vivo Diagnostics, Inflammation, Medicinal chemistry, Metabolic diseases, Metal disorders, Molecular diagnostics, Musculoskeletal disorders, Natural products, Neurological disorders, Obesity, Organic compounds, Personalized medicine, PET, Pharmacology, Receptor, Screening, Signaling, Skin diseases, Target discovery
Research Group:
Radiochemistry for development of radiotracers for Positron Emission Tomography
Olof Solin
olof.solin[at]abo.fi, olof.solin[at]utu.fi
Turku PET Centre and Department of Chemistry,
University of Turku
Ageing-related diseases, Autoimmune diseases, Biomarker, Cancer, Data mining, Diabetes, Disease models, Drug delivery, Drug stability, Drug target, Formulation, Imaging, Imaging software, In Vivo Diagnostics, Inflammation, Metabolic diseases, Molecular diagnostics, Molecular modelling, Nanoparticles, Neurological disorders, NMR, Nucleic acids, Obesity, Organic compounds, Particle size analysis, PET, Physico-chemical properties, Receptor, Signaling, Synthetic chemistry, Target discovery, Zeta potential
Research Group:
Keratins as modulators of epithelial stress responses and regeneration
Diana Toivola
dtoivola[at]abo.fi
Cell Biology, Faculty of Science and Engineering,
Åbo Akademi University
Antibodies, Autoimmune diseases, Basic research, Biochemistry, Biomarker, Biomedicine, Biotechnology, Cancer, Colorectal cancer, Data mining, Diabetes, Disease models, Drug delivery, Electron microscopy, Endocrinology, Formulation, Imaging, Imaging software, Immunology, In Vivo Diagnostics, Inflammation, Metabolic diseases, Molecular Biology, Molecular Cell Biology, Nanoparticles, Obesity, Pathology, PET, Physiology, Proteomics, Receptor, Screening, Signaling, Super-resolution imaging, Target discovery, Ultrasound imaging
Research Group:
Mesoporous drug carriers/ Electrostatics / Pharmaceutical Physics
Jarno Salonen
jarno.salonen[at]utu.fi
Industrial Physics Laboratory,
University of Turku
Biopharmaceuticals, Cancer, Chemical Physics, Diabetes, Drug delivery, Drug solubility, Drug stability, Drug target, Electron microscopy, FTIR or RAMAN spectroscopy, Lead optimization, Microstructure analysis, Nanoparticles, NMR, Obesity, Particle size analysis, Pharmacy, Physico-chemical properties, Physics, Polymorph analysis, Porosity, Powder X-ray diffraction, Preclinical development, Surface area, Thermal analysis, Zeta potential
Research Group:
Brown and white adipose tissue function in humans
Kirsi Virtanen
kirsi.virtanen[at]utu.fi
Institute of Clinical Medicine,
University of Turku
Basic research, Diabetes, Endocrinology, Metabolic diseases, PET, Physiology
